-
80 adolescents a day will still die of AIDS by 2030, despite slowdown in epidemic: UN
biospectrumasia
December 03, 2018
Currently, 3 million persons 19 years and younger, are infected with HIV worldwide
-
European Commission Approves Merck’s DELSTRIGO
firstwordpharma
November 29, 2018
In the United States, both DELSTRIGO and PIFELTRO are indicated for the treatment of HIV-1 infection in adults with no prior antiretroviral treatment experience, and are administered orally once daily...
-
IAVI Announces Clinical Trial of HIV Vaccine Candidate
americanpharmaceuticalreview
October 10, 2018
The International AIDS Vaccine Initiative (IAVI) announces the start of a Phase I clinical trial (IAVI G001) to test a novel vaccine candidate designed to stimulate the immune system to initiate a first step in the generation of potent proteins...
-
Changes of the Global HIV Drug Market in 10 Years
1℃
September 30, 2018
Gilead Sitting Atop, the Quadruple Regimen Genvoya Fast Growing into a Star of Today
-
GSK takes billion-dollar drug fight with Gilead to top AIDS meeting
financialexpress
June 29, 2018
GlaxoSmithKline is taking its fight with Gilead Sciences for dominance of the HIV market to the world’s leading AIDS conference next month by showcasing detailed results from its new two-drug treatment.
-
AIDS charity lambasts “ethically challenged” Gilead over price hikes
pharmafile
January 12, 2018
The AIDS Healthcare Foundation (AHF) has strongly criticised Gilead prices increases across the board for its HIV and AIDS treatment, including pre-exposure prophylaxis (PrEP) drug Truvada.
-
Abbott collaborates with YRGCARE
expressbpd
January 11, 2018
Abbott has announced its partnership with Y R Gaitonde Centre for AIDS Research and Education (YRGCARE) to study the country’s viral diversity to improve accuracy of diagnostic tests.
-
Gilead Commits $100M to Tackle the HIV/AIDS Epidemic in the Southern U.S.
biospace
December 05, 2017
Gilead Announces 10-Year, $100 Million Commitment to Address the HIV/AIDS Epidemic in the Southern United States
-
HIV-screening by GPs could reduce incidence and cost
pharmafile
August 01, 2017
Researchers have found that offering first-time patients a HIV test in an area of high-prevalence could help reduce levels of the infection and the cost of treatment in the long-term
-
AIDS related deaths decline claims UN report
biospectrumasia
July 24, 2017
In APAC region, the majority of new infections are occurring in 10 countries led by India, China, Indonesia, Pakistan, Vietmnam, Myanmar, Papua New Guinea, the Philippines, Thailand and Malaysia